Zomedica Corp.
ZOMDF
$0.11
-$0.01-4.97%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.45M | 28.36M | 27.52M | 27.29M | 26.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.45M | 28.36M | 27.52M | 27.29M | 26.73M |
| Cost of Revenue | 9.40M | 8.68M | 8.15M | 8.20M | 8.12M |
| Gross Profit | 20.06M | 19.68M | 19.38M | 19.09M | 18.61M |
| SG&A Expenses | 43.90M | 44.30M | 45.39M | 46.85M | 48.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.97M | 60.71M | 60.88M | 62.31M | 64.99M |
| Operating Income | -31.52M | -32.35M | -33.36M | -35.03M | -38.26M |
| Income Before Tax | -84.81M | -85.39M | -102.08M | -47.54M | -62.07M |
| Income Tax Expenses | -285.00K | -293.00K | -448.00K | -557.00K | 123.00K |
| Earnings from Continuing Operations | -84.52 | -85.10 | -101.63 | -46.98 | -62.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.52M | -85.10M | -101.63M | -46.98M | -62.19M |
| EBIT | -31.52M | -32.35M | -33.36M | -35.03M | -38.26M |
| EBITDA | -23.43M | -24.14M | -25.09M | -27.04M | -30.45M |
| EPS Basic | -0.09 | -0.09 | -0.10 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.10 | -0.10 | -0.11 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Average Diluted Shares Outstanding | 3.92B | 3.92B | 3.92B | 3.92B | 3.92B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |